Table 4 Answers to PAD questionnaire applied to investigators expressed as n(%) (n = 53)
In which age group (years) of your patients do you consider to measure ABI in your clinic? | ||||||
|---|---|---|---|---|---|---|
|  | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | ≥80 |
For male patients | 40 (75.5) | 29 (54.7) | 31 (58.5) | 21 (39.6) | 20 (37.7) | 17 (32.1) |
For female patients | 31 (58.5) | 31 (58.5) | 32 (60.4) | 21 (39.6) | 20 (37.7) | 17 (32.1) |
Do you evaluate obese patients by physical examination and ABI with the suspect of PAD? | ||||||
Yes | 24(45.3) | |||||
Do you evaluate diabetic patients by physical examination and ABI with the suspect of PAD | ||||||
Yes | 35(66.0) | |||||
Do you evaluate smokers by physical examination and ABI with the suspect of PAD? | ||||||
Yes | 33(62.5) | |||||
What are the objectives of PAD treatment according to Turkish Society of Cardiovascular Surgery? | ||||||
To control symptoms | 39(73.6) | |||||
To prevent amputation | 45(84.9) | |||||
To increase survival | 46(86.8) | |||||
Do "patient history" and "physical examination" show that your patient has PAD? | ||||||
Yes | 12(22.6) | |||||
What should be the option(s) of your patient for the further investigation of PAD? | ||||||
ABI + Doppler | 50(94.3) | |||||
Cardiovascular surgery consultation | 16(30.2) | |||||
Nothing, routine follow up | 3(5.7) | |||||
What are the treatments of choice for ischemic events? | ||||||
| Â | Continue | Add | Stop | Contraindicate | ||
ASA | 48(92.5) | 16(30.2) | 0(0.0) | 0(0.0) | ||
Clopidogrel | 30(56.6) | 28(52.8) | 0(0.0) | 0(0.0) | ||
Cilostazole | 9(17) | 12(22.6) | 0(0.0) | 0(0.0) | ||
Statins | 41(77.4) | 24(45.3) | 0(0.0) | 0(0.0) | ||
Other lipid lowering drugs | 26(49.1) | 22(41.5) | 1(1.9) | 0(0.0) | ||
ACE inhibitors | 38(71.7) | 21(39.6 | 0(0.0) | 0(0.0) | ||
Other antihypertensives | 24(45.3) | 24(45.3) | 3(5.7) | 1(1.9) | ||
Warfarin | 23(43.4) | 21(39.6) | 3(5.7) | 0(0.0) | ||
Antihyperglycemic drug | 40(75.5) | 17(32.1) | 0(0.0) | 0(0.0) | ||
Stop smoking program | 45(85.9) | 20(37.7) | 1(1.9) | 1(1.9) | ||
Walking-exercise prog. | 43(81.1) | 23(43.4) | 1(1.9) | 0(0.0) | ||